Room for improvement: A systematic review of the quality of evaluations of interventions to improve hospital antibiotic prescribing

Journal of Antimicrobial Chemotherapy

Volumn 52, Issue 5, 2003, Pages 764-771

  Ramsay, Craig ^a   Brown, Erwin ^b   Hartman, Giles ^c   Davey, Peter ^d  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b FRENCHAY HOSPITAL   (United Kingdom)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

^d UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Controlled before and after studies; Hospital antibiotic prescribing; Interrupted time series; Prescribing interventions; Segmented regression analysis

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CEFAZOLIN; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; METRONIDAZOLE; VANCOMYCIN;

ANTIBIOTIC THERAPY; ANTIMICROBIAL THERAPY; CLINICAL OBSERVATION; CLINICAL PRACTICE; CLINICAL PROTOCOL; CLINICAL STUDY; COCHRANE LIBRARY; CORRELATION FUNCTION; DATA ANALYSIS; EVIDENCE BASED MEDICINE; HEALTH CARE ORGANIZATION; HOSPITAL CARE; HOSPITAL INFECTION; HOSPITAL PATIENT; HUMAN; MEDICAL LITERATURE; MEDICAL RESEARCH; MEDICAL SOCIETY; METHODOLOGY; PRESCRIPTION; PUBLICATION; REGRESSION ANALYSIS; REVIEW; STATISTICAL ANALYSIS; UNITED KINGDOM;

ANTI-BACTERIAL AGENTS; HOSPITALS; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; PROGRAM EVALUATION; RESEARCH DESIGN;

EID: 0242437868     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkg460     Document Type: Review

References (47)

1. House of Lords Select Committee on Science and Technology. (1998). Resistance to Antibiotics and Other Antimicrobial Agents. Session 1997-98, 7th Report, pp. 1-108. The Stationery Office, London, UK.
2. House of Lords Select Committee on Science and Technology. (2001). Resistance to Antibiotics. Session 2000-01, 3rd Report, pp. 1-34. The Stationery Office, London, UK.
3. European Union Conference. (1998). The Copenhagen Recommendations. Report from the Invitational EU Conference on The Microbial Threat, pp. 1-52. Ministry of Health, Ministry of Food, Agriculture and Fisheries, Copenhagen, Denmark http://www.im.dk/publikationer/micro98/index.htm.
4. Standing Medical Advisory Committee, Subcommittee on Antibiotic Resistance. (1998). The Path of Least Resistance (Hart, M., Livermore, D. M. & Weinberg, J. R., Eds), pp. 1-152. Department of Health, London, UK.
5. Wagner, A. K., Soumerai, S. B., Zhang, F. et al. (2002). Segmented regression analysis of interrupted time series studies in medication use research. Journal of Clinical Pharmacy and Therapeutics 27, 299-309.
6. The Cochrane Effective Practice and Organisation of Care Group (EPOC). The Data Collection Checklist. (2002). Cochrane Effective Practice and Organisation of Care Group (EPOC) Methods Papers [Online.] http://www.epoc.uottawa.ca/ (22 April 2003, date last accessed).
7. Abramowitz, P. W., Nold, E. G. & Hatfield, S. M. (1982). Use of clinical pharmacists to reduce cefamandole, cefoxitin and ticarcillin costs. American Journal of Hospital Pharmacy 39, 1176-80.
8. Adachi, W., Bolding, F. & Armstrong, R. (1997). Experience with vancomycin education and order sheet to limit vancomycin use. Hospital Pharmacy 32, 1370-3.
9. Avorn, J., Soumerai, S. B., Taylor, W. et al. (1988). Reduction of incorrect antibiotic dosing through a structured educational order form. Archives of Internal Medicine 148, 1720-4.
10. Belliveau, P. P., Rothman, A. L. & Maday, C. E. (1996). Limiting vancomycin use to combat vancomycin- resistant Enterococcus faecium. American Journal of Health Systems Pharmacy 53, 1570-5.
11. Bradley, S. J., Wilson, A. L. T., Allen, M. C. et al. (1999). The control of hyperendemic glycopeptide-resistant Enterococcus spp. on a haematology unit by changing antibiotic usage. Journal of Antimicrobial Chemotherapy 43, 261-6.
12. Bunz, D., Gupta, S. & Jewesson, P. (1990). Metronidazole cost containment: a two-stage intervention. Hospital Formulary 25, 1167-77.
13. Burke, C. E., Piper, J. & Holloway, W. (1997). Order form for restricting vancomycin prescribing. American Journal of Health Systems Pharmacy 54, 1893, 1897.
14. Climo, M. W., Israel, D. S. & Wong, E. S. (1998). Hospital-wide restriction of clindamycin: effect on the incidence of Clostridium difficile-associated diarrhea and cost. Annals of Internal Medicine 128, 989-95.
15. de Champs, C., Franchineau, P. & Gourgand, J. M. (1994). Clinical and bacteriological survey after change in aminoglycoside treatment to control an epidemic of Enterobacter cloacae. Journal of Hospital Infection 28, 219-29.
16. Dempsey, C. L. (1995). Nursing home-acquired pneumonia: outcomes from a clinical process improvement program. Pharmacotherapy 15, 33S-38S.
17. Everitt, D. E., Soumerai, S. B., Avorn, J. et al. (1990). Changing surgical antimicrobial prophylaxis practices through education targeted at senior department leaders. Infection Control and Hospital Epidemiology 11, 578-83.
18. Gupta, S., Bachand, R. L. & Jewesson, P. J. (1989). Impact of a two-stage intervention program on cefazolin usage at a major teaching hospital. Hospital Formulary 24, 41-4, 46.
19. Hampson, J. P., Corkhill, J. E., Murray, A. et al. (1988). Potential financial benefits of a local antibiotic policy. Pharmaceutical Journal Novermber 19, 660-2.
20. Hess, D. A., Mahoney, C. D., Johnson, P. N. et al. (1990). Integration of clinical and administrative strategies to reduce expenditures for antimicrobial agents. American Journal of Hospital Pharmacy 47, 585-91.
21. Himmelberg, C. J., Pleasants, R. A., Weber, D. J. et al. (1991). Use of antimicrobial drugs in adults before and after removal of a restriction policy. American Journal of Public Health 48, 1220-7.
22. Huber, S. L., Patry, R. A. & Hudson, H. D. (1982). Influencing drug use through prescribing restrictions. American Journal of Hospital Pharmacy 39, 1898-901.
23. Inaraja, M. T., Paloma, J. M., Giraldez, J. et al. (1986). Computer-assisted antimicrobial-use monitoring. American Journal of Hospital Pharmacy 43, 664-70.
24. Kolar, M. & Latal, T. (1999). Implementation of a practical antibiotic policy in the Czech Republic. Infection Control and Hospital Epidemiology 20, 440-3.
25. Landman, D., Chockalingam, M. & Quale, J. M. (1999). Reduction in the incidence of methicillin-resistant Staphylococcus aureus and ceftazidime-resistant Klebsiella pneumoniae following changes in a hospital antibiotic formulary. Clinical Infectious Diseases 28, 1062-6.
26. Lautenbach, E., LaRosa, L. A., Marr, A. M. et al. (2003). Changes in the prevalence of vancomycin-resistant enterococci in response to antimicrobial formulary interventions: impact of progressive restrictions on use of vancomycin and third-generation cephalosporins. Clinical Infectious Diseases 36, 440-6.
27. Lee, J., Carlson, J. A. & Chamberlain, M. A. (1995). A team approach to hospital formulary replacement. Diagnostic Microbiology and Infectious Disease 22, 239-42.
28. McElnay, J. C., Scott, M. G., Sidara, J. Y. et al. (1995). Audit of antibiotic usage in medium-sized general hospital over an 11-year period. The impact of antibiotic policies. Pharmacy World and Science 17, 207-13.
29. McGowan, J. E. & Finland, M. (1976). Effects of monitoring the usage of antibiotics: an interhospital comparison. Southern Medical Journal 69, 193-5.
30. McGowan, J. E. & Finland, M. (1974). Usage of antibiotics in a general hospital: effect of requiring justification. Journal of Infectious Diseases 130,165-8.
31. McNulty, C., Logan, M., Donald, I. P. et al. (1997). Successful control of Clostridium difficile infection in an elderly care unit through use of a restrictive antibiotic policy. Journal of Antimicrobial Chemotherapy 40, 707-11.
32. Mercer, K. A., Chintalapudi, S. R. & Visconti, E. B. (1999). Impact of targeted antibiotic restriction on usage and cost in a community hospital. Journal of Pharmacy Technology 15, 79-84.
33. Meyer, K. S., Urban, C., Eagan, J. A. et al. (1993). Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins. Annals of Internal Medicine 119, 353-8.
34. Patel, M. & Jackson, C. (1989). Targeted interventions on oral antibiotic expenditure. British Journal of Pharmaceutical Practice August, 306-8.
35. Pear, S. M., Williamson, T. H., Bettin, K. M. et al. (1994). Decrease in nosocomial Clostridium difficile-associated diarrhea by restricting clindamycin use. Annals of Internal Medicine 120, 272-7.
36. Richardson, L. P., Wiseman, S. W., Melani, P. N. et al. (2000). Effectiveness of a vancomycin restriction policy in changing the prescribing patterns of house staff. Microbial Drug Resistance 6, 327-30.
37. Saizy-Callaert, S., Causse, R., Furhman, C. et al. (2003). Impact of a multidisciplinary approach to the control of antibiotic prescription in a general hospital. Journal of Hospital Infection 53, 177-82.
38. Salama, S., Rotstein, C. & Mandell, L. (1996). A multidisciplinary hospital-based antimicrobial use program: impact on hospital pharmacy expenditures and drug use. Canadian Journal of Infectious Diseases 7, 104-9.
39. Sirinavin, S., Suvanakoot, P., Sathapatayavongs, B. et al. (1998). Effect of antibiotic order form guiding rational use of expensive drugs on cost containment. Southeast Asian Journal of Tropical Medicine and Public Health 29, 636-42.
40. Stevenson, R. C., Blackman, S. C., Williams, C. L. et al. (1988). Measuring the saving attributable to an antibiotic prescribing policy. Journal of Hospital Infection 11, 16-25.
41. Toltzis, P., Yamashita, T., Vilt, L. et al. (1998). Antibiotic restriction does not alter endemic colonization with resistant gram-negative rods in a pediatric intensive care unit. Critical Care Medicine 26, 1893-9.
42. Wilson, J., Gordon, A., French, S. et al. (1991). The effectiveness of prescribers newsletters in influencing hospital drug expenditure. Hospital Pharmacy Practice May, 33-8.
43. Woodward, R. S., Medoff , G., Smith, M. D. et al. (1987). Antibiotic cost savings from formulary restrictions and physician monitoring in a medical-school-affiliated hospital. American Journal of Medicine 83, 817-23.
44. Young, E. J., Sewell, C. M., Koza, M. A. et al. (1985). Antibiotic resistance patterns during aminoglycoside restriction. American Journal of the Medical Sciences 290, 223-7.
45. Altman, D. G. (1994). The scandal of poor medical research: we need less research, better research, and research done for the right reasons. British Medical Journal 308, 283-4.
46. Cook, T. D. & Campbell, D. T. (1979). Quasi Experimentation. Design & Analysis Issues for Field Settings. Houghton Mifflin Company, Boston, MA, USA.
47. Soumerai, S. B., McLaughlin, T. J. & Avorn, J. (1989). Improving drug prescribing in primary care: a critical analysis of the experimental literature. Milbank Quarterly 67, 268-317.